Results 21 to 30 of about 13,477 (288)
Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension [PDF]
Clinical Ophthalmology, 2012 Fernanda Pacella, Paolo Turchetti, Valentina Santamaria, David Impallara, Gianpaolo Smaldone, Chiara Brillante, Aloisa Librando, Angela Damiano, Jose Pecori-Giraldi, Elena PacellaDepartment of Sense Organs, University of Rome "Sapienza ...
Pacella F +8 more
doaj +3 more sources
Efficacy and tolerability of a large scale change in regimen from latanoprost to travoprost in glaucoma patients at the Manhattan Veterans Administration Hospital [PDF]
Clinical Ophthalmology, 2008 Edmund P FarrisNew York University, New York, NY; Manhattan Veterans Administration Hospital, New York, NY; New York Medical College, Valhalla, NY, USAObjective: This retrospective study was designed to investigate the efficacy and tolerability of ...
Edmund P Farris
doaj +3 more sources
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial [PDF]
International Journal of Ophthalmology, 2021 AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free (PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride (BAK)-preserved latanoprost [Xalatan®] in patients with primary open ...
Joon Mo Kim +5 more
doaj +1 more source
Latanoprost and Cystoid Macular Edema
Journal of Cataract and Refractive Surgery, 2003 Anil Negi
+11 more sources
Latanoprost eye drops induce conjunctival lymphatic vessel development [PDF]
International Journal of Ophthalmology, 2021 AIM: To investigate the effect of latanoprost eye drops on the conjunctival lymphatics. METHODS: Twenty-four healthy New Zealand White rabbits weighing 1.5 to 2.0 kg were randomly divided into three groups: latanoprost group (n=8) administered with ...
Kai Ma +3 more
doaj +1 more source
Cosmetics, 2023 Eyelashes, in addition to fulfilling eye-protective functions, generate an aesthetic impact. Latanoprost is a prostaglandin analog, commonly used for the treatment of glaucoma and intraocular hypertension.
Janette Ivone Espinoza-Silva +3 more
doaj +1 more source
Translational Vision Science & Technology, 2022 Purpose To evaluate the ocular hypotensive efficacy and safety of razuprotafib, a novel Tie2 activator, when used as an adjunct to latanoprost in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
M. Brigell +3 more
semanticscholar +1 more source
Journal of glaucoma, 2022 Précis: NCX 470 0.042% and 0.065% were statistically superior in intraocular pressure (IOP) lowering to latanoprost 0.005%, and NCX 470 0.021% was noninferior. All NCX 470 concentrations were safe and well tolerated.
T. Walters +7 more
semanticscholar +1 more source
Mass spectrometry in ocular drug research
Mass Spectrometry Reviews, EarlyView., 2023 Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo +6 more
wiley +1 more source
Korean Journal of Ophthalmology, 2022 Purpose Netarsudil is a Rho kinase inhibitor and the first new class of clinically useful ocular hypotensive agents. In this study, we conducted a systematic literature review and meta-analysis to summarize and synthesize the available evidence on the ...
Jong-wook Lee +6 more
semanticscholar +1 more source